Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Sarah A. Paschall

3 papers in the library · 5 citations · publishing 2023-2025

Papers

Psychedelics and schizophrenia: A mystery in history

Journal of Psychedelic Studies December 2, 2023 Mark Haden, Birgitta Woods, Sarah A. Paschall 3 citations

A review of current and historical research and clinical reports finds that the relationship between psychedelics and schizophrenia is complex, with some evidence that psychedelics may benefit this population. Specifically, lower doses of psychedelics, mostly LSD, appear to have a potential beneficial impact on the negative symptoms of schizophrenia.

Beyond prohibition: A public health analysis of naturalistic psychedelic use

Journal of Psychedelic Studies July 3, 2025 Mark Haden, Sarah A. Paschall, Birgitta Woods 2 citations

A review of 104 peer-reviewed articles finds that naturalistic use of psychedelics like psilocybin, LSD, MDMA, mescaline, and 5-MeO-DMT is associated with reductions in depression, anxiety, PTSD, substance use disorders, interpersonal violence, and suicidality, while enhancing emotional well-being, social connectedness, spirituality, nature relatedness, psychological flexibility, and physical health. Benefits appear across diverse populations, including those with trauma, addictions, chronic pain, older adults, and marginalized groups. Adverse effects are typically short-lived and linked to risk factors like youth, high doses, psychological vulnerability, and poor set and setting. The authors argue that prohibitionist policies are outdated and harmful, advocating for legalization, regulated access, and evidence-informed education grounded in harm reduction and Indigenous cultural models.

Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days.

Psychopharmacology October 11, 2025 Michelle St Pierre, Elena Argento, Jordyn Cates et al.

On days when adults microdose psychedelics, they report higher levels of wellbeing, productivity, creativity, connectedness, contemplation, and focus compared to days they do not microdose. The increase in creativity is especially pronounced among people who have previously used larger doses of psychedelics. These findings come from a large international survey of 1,435 adults who microdose, using daily-level self-reports that reduce reliance on memory. Because the study is observational and exploratory, the results should be interpreted cautiously.